ATRION CORPORATION (ATRI) Stock Price, Forecast & Analysis
USA - NASDAQ:ATRI - US0499041053 - Common Stock
ATRI Key Statistics, Chart & Performance
The current stock price of ATRI is 459.92 USD. In the past month the price increased by 0.48%. In the past year, price increased by 0.88%.
ATRI Latest News, Press Relases and Analysis
ATRI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 17.95 | 14.35B | ||
| SOLV | SOLVENTUM CORP | 12.83 | 13.22B | ||
| ALGN | ALIGN TECHNOLOGY INC | 13.92 | 9.76B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.36 | 5.15B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.72 | 3.53B | ||
| HAE | HAEMONETICS CORP/MASS | 15.61 | 3.61B | ||
| ICUI | ICU MEDICAL INC | 17.25 | 3.39B | ||
| XRAY | DENTSPLY SIRONA INC | 6.63 | 2.09B | ||
| UFPT | UFP TECHNOLOGIES INC | 25.95 | 1.73B | ||
| NEOG | NEOGEN CORP | 21.67 | 1.41B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.30B | ||
| EMBC | EMBECTA CORP | 4.99 | 852.20M |
Related stock screener links
About ATRI
Company Profile
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Company Info
ATRION CORPORATION
One Allentown Parkway
Allen TEXAS 75002 US
CEO: David A. Battat
Employees: 712
Phone: 19723909800
ATRION CORPORATION / ATRI FAQ
What does ATRION CORPORATION do?
Atrion Corp. engages in the manufacture and development of products for medical applications. The company is headquartered in Allen, Texas and currently employs 712 full-time employees. The firm's medical products are used in a number of fields including fluid delivery, cardiovascular, and ophthalmic applications. The company has developed a variety of proprietary valves designed to precisely fill, hold, and release and/or remove controlled amounts of fluids, including blood and drugs, or gasses on demand for use in areas such as intubation, intravenous, catheter, and other applications in fields including anesthesia and oncology. The core of its cardiovascular products is its Myocardial Protection System, a technology that is the only open-heart surgery system that delivers to the heart essential fluids and medications, mixes critical drugs, and controls temperature, pressure, and other important variables. The firm also manufactures a line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults.
Can you provide the latest stock price for ATRION CORPORATION?
The current stock price of ATRI is 459.92 USD. The price increased by 0.06% in the last trading session.
Does ATRION CORPORATION pay dividends?
ATRION CORPORATION (ATRI) has a dividend yield of 1.91%. The yearly dividend amount is currently 8.6.
What is the ChartMill rating of ATRION CORPORATION stock?
ATRI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What sector and industry does ATRION CORPORATION belong to?
ATRION CORPORATION (ATRI) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the ownership details for ATRI stock?
You can find the ownership structure of ATRION CORPORATION (ATRI) on the Ownership tab.
ATRI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ATRI. When comparing the yearly performance of all stocks, ATRI is a bad performer in the overall market: 67.28% of all stocks are doing better.
ATRI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ATRI. ATRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
ATRI Financial Highlights
Over the last trailing twelve months ATRI reported a non-GAAP Earnings per Share(EPS) of 7.13. The EPS decreased by -53.54% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.92% | ||
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| Debt/Equity | 0 |